Biologics CDMO
6 listings from 6 suppliers · 2 Japanese makers
Japanese name: バイオ医薬 CDMO（受託開発製造）
Biologics CDMOs take on development and manufacturing of antibodies, biologic drug substances, and gene and cell therapies. Developers without their own facilities, or who need extra capacity, use them from cell line construction through clinical and commercial supply. In practice the comparison covers the modalities handled, production scale, site locations in Japan and overseas, and regulatory track record. Below are CDMOs by maker, grouped into domestic and global large CDMOs.
| Product | Maker | Where to buy in Japan |
|---|---|---|
| Biopharmaceutical CDMO (drug substance and drug product) | CMICJP maker | From the maker |
| Pharmaceutical contract manufacturing (CDMO) | Seikagaku CorporationJP maker | From the maker |
| Product | Maker | Where to buy in Japan |
|---|---|---|
| Biopharmaceutical and gene and cell therapy CDMO | AGC Biologics | Not yet confirmed |
| Biologics CDMO | FUJIFILM Diosynth Biotechnologies | Not yet confirmed |
| Biologics CDMO | Lonza | Not yet confirmed |
| End-to-End Biologics CDMO | Samsung Biologics | Not yet confirmed |
“Where to buy in Japan” shows only sales relationships we have confirmed on the company’s or the distributor’s own website. “Not yet confirmed” means we have not checked yet, not that the product is unavailable in Japan. Product names link to the maker’s own page.